Crystalline methamphetamine: risks, harms and interventions


In recent years, concerns about crystalline methamphetamine use have increased in multiple countries. Taking the drug regularly can lead to dependence, anxiety, depression, psychosis and, in some cases, overdose deaths. In this podcast, Raj Persaud talks to Professor Michael Farrell about these associated harms, and the possible preventative strategies that can be adopted.


Date published: 28 July 2016

Presenter: Dr Raj Persaud

Interviewee: Professor Michael Farrell

Audio running time: 19 minutes

Credits: 0.5


Learning outcomes


By the end of this podcast, we hope you will have gained an understanding of:


  • the common effects of taking crystalline methamphetamine


  • the psychological risks associated with taking the drug


  • preventative measures and interventions that can be effective


  • effective ways of communicating with patients and young people about this drug.


Take the module test and gain CPD certification

Having problems downloading or playing the podcast file? View our troubleshooting page.


If you like this podcast, you may also be interested in the following:


Module Stimulants: epidemiology and impact on mental health by Professor Fabrizio Schifano and Dr Antonio Albanese


RCPsych book The Drug Conversation: How to talk to your child about drugs by Dr Owen Bowden-Jones

© 2021 Royal College of Psychiatrists